GB1022214A - Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation - Google Patents
Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparationInfo
- Publication number
- GB1022214A GB1022214A GB356264A GB356264A GB1022214A GB 1022214 A GB1022214 A GB 1022214A GB 356264 A GB356264 A GB 356264A GB 356264 A GB356264 A GB 356264A GB 1022214 A GB1022214 A GB 1022214A
- Authority
- GB
- United Kingdom
- Prior art keywords
- prepared
- amino
- formula
- naphthyridine
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
The invention comprises compounds of the formula <FORM:1022214/C2/1> where X is carboxy, a carboxy salt, C2- 7 carbalkoxy, carbamoyl, cyano or another group convertible to carboxy by hydrolysis, R is C1-6 alkyl, R5 is hydrogen or C1-6 alkyl, and R6 and R8 are each hydrogen, C1-6 alkyl, C1-6 alkoxy, hydroxy, amino or C2-6 alkanoylamine, and 7-N-oxides thereof. The compounds may be prepared by reacting a compound of the formula <FORM:1022214/C2/2> with an ester of the formula R1An, where An is an anion of strong inorganic acid or an organic sulphonic acid, in the presence of an acid acceptor. The free acids (X = carboxy) may also be prepared by hydrolysis of the corresponding esters (X = 3-carbalkoxy), or by hydrogenating the corresponding 7-N-oxides. The 7-N-oxides are prepared by either 1-N-alkylating the 4-hydroxy-3X-1,7-naphthyridine 7-N-oxides or by reacting a compound of formula I with an oxidizing agent. The 6 - hydroxy - 1,4 - dihydro - 4 - oxo - 1 - R1 - 5-R5 - 8 - R8 - 1,7 - naphthyridine - 3 - carboxylic acids may also be prepared by converting the 6 - amino - 1,4 - dihydro - 4 - oxo - 1 - R1 - 5-R5 - 8 - R8 - 1,7 - naphthyridines into the corresponding diazonium salts and hydrolysing the diazonium salts. The 6-amino-1,4-dihydro-4 - oxo - 1 - R1 - 5 - R5 - 8 - R8 - 1,7 - naphthyridines may also be prepared by reacting C1-alkyl 6 - acylamino - 1,4 - dihydro - 5-R5 - 8 - R8 - 1,7 - naphthyridine carboxylates with an ester R1An to obtain the corresponding C1-6 alkyl 6-acylamino-1,4-dihydro-4-oxo-1-R1-5-R5-8-R8-1, 7-naphthyridine carboxylates which are then hydrolysed with an acidic agent to remove both the ester and N-acyl groups. The compounds of Formula II where X is a C2-7 carbalkoxy group and R8 is other than hydrogen are prepared by reacting a 3-amino-2-R8-5-R5-6-R6-pyridine with one molar equivalent of a dialkyl ethoxymethylenemalonate to yield a dialkyl N-(2-R8-5-R5-6-R6-3-pyridylamino)methylene malonate and then cyclizing this compound by heating in an appropriate solvlent. The compounds of Formula II where X is a C2-7 carbalkoxy group and R8 is hydrogen are prepared by reacting a 3-amino-5-R5-6-R6-pyridine with a dialkyl ethoxymethylene malonate to yield a dialkyl N-(5-R5-6-R6-3-pyridylamino)methylene malonate, preparing the 1-oxide of this compound, cyclizing the 1-oxide by heating in an appropriate solvent to produce a 3 - carbalkoxy - 4 - hydroxy - 5 - R5 - 6 - R6-1,7-naphthyridine-7-oxide which is then hydrogenated to remove the 7-oxygen atom. The compounds of Formula II where X is carboxy, and 7-N-oxides thereof, may also be prepared by hydrolysing the corresponding 3-C2-7 carbalkoxy derivatives. 3 - Cyano - 6,8 - dimethyl - 4 - hydroxy-1,7 - naphthyridine is prepared by cyclizing N - (2,6 - dimethyl - 3 - pyridyl)aminomethyl-enecyanoacetate, itself prepared by reacting 3 - amino - 2,6 - dimethyl - pyridine with ethyl ethoxymethylenecyanoacetate. 6 - Acetamido 2 methyl - 3 - amino pyridine is prepared by acylating 6-amino-2-methyl-3-nitro pyridine with acetic anhydride or acetyl chloride and hydrogenating the resulting 6-acetamido - 2 - methyl - 3 - nitro - pyridine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25521063A | 1963-01-31 | 1963-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1022214A true GB1022214A (en) | 1966-03-09 |
Family
ID=22967324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB356264A Expired GB1022214A (en) | 1963-01-31 | 1964-01-28 | Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1022214A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856800A (en) * | 1973-02-26 | 1974-12-24 | Sterling Drug Inc | Process of preparing 1,4-dihydro-4-oxo-7-q-3-unsubstituted-1,8-naphthyridines from cyclic alkylidenyl n-(6-q-2-pyridyl) aminomethylenemalonates |
EP0059291A1 (en) * | 1981-02-27 | 1982-09-08 | American Home Products Corporation | Antihypertensive agents |
WO2003101988A2 (en) * | 2002-05-31 | 2003-12-11 | Bayer Pharmaceuticals Corporation | Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
JP2017105818A (en) * | 2006-10-16 | 2017-06-15 | バイオノミクス リミテッド | Novel anxiolytic compounds |
US10844055B2 (en) | 2016-10-21 | 2020-11-24 | Novartis Ag | Naphthyridinone derivatives and their use in the treatment of arrhythmia |
-
1964
- 1964-01-28 GB GB356264A patent/GB1022214A/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856800A (en) * | 1973-02-26 | 1974-12-24 | Sterling Drug Inc | Process of preparing 1,4-dihydro-4-oxo-7-q-3-unsubstituted-1,8-naphthyridines from cyclic alkylidenyl n-(6-q-2-pyridyl) aminomethylenemalonates |
EP0059291A1 (en) * | 1981-02-27 | 1982-09-08 | American Home Products Corporation | Antihypertensive agents |
WO2003101988A2 (en) * | 2002-05-31 | 2003-12-11 | Bayer Pharmaceuticals Corporation | Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
WO2003101988A3 (en) * | 2002-05-31 | 2004-04-15 | Bayer Pharmaceuticals Corp | Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
JP2017105818A (en) * | 2006-10-16 | 2017-06-15 | バイオノミクス リミテッド | Novel anxiolytic compounds |
US10844055B2 (en) | 2016-10-21 | 2020-11-24 | Novartis Ag | Naphthyridinone derivatives and their use in the treatment of arrhythmia |
US11530213B2 (en) | 2016-10-21 | 2022-12-20 | Novartis Ag | Naphthyridinone derivatives and their use in the treatment of arrhythmia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK543787A (en) | NAPHTHYRIDINE, QUINOLINE AND BENZOXAZINE CARBOXYLIC ACID COMPOUNDS WITH ANTIBACTERIAL ACTIVITY | |
AR241183A1 (en) | Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido{1,2,3-de]{1, 4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4- dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carb | |
NO933393L (en) | quinolone carboxylic acids | |
CS51492A3 (en) | 2-substituted quinolines, process of their preparation and their use inmedicaments | |
IE38393L (en) | Derivatives of quinoline and related compounds. | |
GB1022214A (en) | Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation | |
DD280530A5 (en) | METHOD FOR PRODUCING L-TERTIAER-ALKYL-SUBSTITUTED NAPHTHYRIDINE AND CHINOLINE-CARBONSAEURES AND CARBONSAFE DERIVATIVES | |
SE8305539D0 (en) | INTERMEDIATES FOR THE PREPARATION OF 7-ACYLAMIDO-3- (1-CARBOXY- (LOWER ALKYL) -TETRZOL-5-YLTIOMETHYL) -3-CEFEM-4-CARBOXYL ACID | |
ES510336A0 (en) | "A PROCEDURE FOR PREPARING A DERIVATIVE OF B-LACTAMA-ACETIC ACID". | |
YU45810B (en) | PROCESS FOR THE PREPARATION OF QUINOLINE CARBOXYLIC ACIDS | |
ES392290A1 (en) | Tetrahydro-oxofuroquinoline carboxylic acid derivatives | |
GB1115254A (en) | New aminopyrazolopyridine derivatives compounds and process for the manufacture thereof | |
NO177302C (en) | Analogous Process for Preparing Therapeutically Active Substituted Azetidinyl Quinolone (Naphthyridone) Carboxylic Acid Derivatives | |
GB1259814A (en) | Benzimidazoles | |
ATE138912T1 (en) | PRODUCTION OF HIGHER ALKYL ESTERS OF CARBOXYLIC ACID | |
GB1436304A (en) | Pyridine and pyridine oxide derivatives and processes for their preparation | |
GR1000469B (en) | Preparation method of quinoline carboxylic acids | |
GB1342807A (en) | Process for the preparation of alphaanilinocarboxylic acids and or derivatives thereof | |
GB1017979A (en) | Improvements in or relating to the preparation of chloro-acetoacetamides and to substituted dioxolan derivatives of acetic acid esters as intermediates in said preparation | |
SE7713710L (en) | PREPARATION OF NEW ETRs | |
GB1122435A (en) | Process for the preparation of derivatives of quinoline 3-carboxylates | |
JPS6442488A (en) | Production of 7-acylaminodeacetoxycephalosporanic acid or ester thereof | |
FR2317922A1 (en) | Antiallergic (3)-phenyl or benzyl isocoumarins - are prepd. from a phthalic anhydride and homophthalic acid | |
GB1182369A (en) | 0,7-Naphthyridine Derivatives | |
GB1022936A (en) | Amide derivatives of d-lysergic acid |